Jasper Therapeutics Stock
Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic
Sign up today and learn more about Jasper Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Jasper Therapeutics Stock
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Investors
Abingworth
Roche Venture Fund
Funding History
| December 2019 | $35.0M |
|---|---|
| January 2020 | $0 |
| January 2020 | $14.1M |
Management
Co-Founder & Vice President Operations & Program Management
Susan Prohaska
Co-Founder & Member Board of Directors
Judith Shizuru M.D.
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
